📰 Expanded Access Program News
Page 14 - Expanded Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Program. Real-time updates on events, politics, business and more.
September 7, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced results from KRYSTAL-1, a multicohort...
September 7, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced results from KRYSTAL-1, a multicohort...
August 31, 2022
/PRNewswire/ -- WideTrial, Inc. will provide key regulatory support to a personalized cancer treatment program run by the Jaime Leandro Foundation for...
August 17, 2022
Developed as the first stand-alone standard of care first-line therapy for NTM disease caused by Mycobacterium avium complex (MAC) infection, RHB-204 is...
August 8, 2022
/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...
July 30, 2022
AIM ImmunoTech has reported positive initial pilot study data from its Phase III trial of an investigational drug, Ampligen, for long Covid.
July 29, 2022
VolitionRx Limited announced that it has commenced an underwritten public offering of common stock. The size and scope of the offering will depend on market...
July 29, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an update on its multipronged response to monkeypox in the United States, including...
July 29, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an update on its multipronged response to monkeypox in the United States, including...
July 28, 2022
AIM ImmunoTech Inc (NYSE:AIM) has announced what it calls positive preliminary pilot study data from its ongoing Expanded Access Program (EAP) evaluating...